[Optimization of pharmacological therapy for weakness syndrome in incurable patients]
| Autor: | A A, Ryazankina, S A, Rozengard, V A, Glushchenko, A P, Karitsky, A V, Kvashnin |
|---|---|
| Rok vydání: | 2015 |
| Předmět: |
Adult
Male Serotonin Dopamine Adamantane Antineoplastic Agents Ibuprofen Radiation-Protective Agents Dexamethasone Neoplasms Acetamides Humans Hypnotics and Sedatives Pentoxifylline Fatigue Aged Aged 80 and over Muscle Weakness Anti-Inflammatory Agents Non-Steroidal Syndrome Middle Aged Ondansetron Treatment Outcome Antiemetics Drug Therapy Combination Female Serotonin Antagonists |
| Zdroj: | Voprosy onkologii. 61(2) |
| ISSN: | 0507-3758 |
| Popis: | In this work there is considered the possibility of correction of therapy for weakness syndrome in incurable patients with the use of drugs affecting dopamine and serotonin exchanges. It is showed that the use of 100 mg of ladasten, 16 mg of ondansetron orally per day and 50 mg of agomelatine per night is more effective in therapy for fatigue/weakness syndrome in incurable cancer patients compared to standard therapy. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|